Maravai LifeSciences Holdings, Inc. (MRVI) CEO Carl Hull on Q2 2022 Results - Earnings Call Transcript [Seeking Alpha]
Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI)
Company Research
Source: Seeking Alpha
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVICompany ParticipantsDeb Hart - Head of Investor RelationsCarl Hull - Chief Executive OfficerKevin Herde - Chief Financial OfficerConference Call ParticipantsMax Smock - William Blair & CompanyMatthew Sykes - Goldman SachsTejas Savant - Morgan StanleyPaul Knight - KeyBanc Capital Inc.Michael Ryskin - Bank of AmericaBrandon Couillard - Jefferies Group LLCJohn Sourbeer - UBS Group AGThank you, Vikram, and good afternoon, everyone. Thanks for joining us on our Second Quarter 2022 Earnings Call. Carl Hull, our Chairman and Chief Executive Officer; and Kevin Herde, our Executive Vice President and Chief Financial Officer. Our correct press release and the slides that accompany todayâ??s call are posted on our website.If you look at the version of the press release that has our EBITDA margins at XX percent, please refresh your browser or go to our investor website at investors.maravai.com for financial information and quarterly results for the
Show less
Read more
Impact Snapshot
Event Time:
MRVI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRVI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRVI alerts
High impacting Maravai LifeSciences Holdings, Inc. - Class A common stock news events
Weekly update
A roundup of the hottest topics
MRVI
News
- TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production [Yahoo! Finance]Yahoo! Finance
- TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance ProductionBusiness Wire
- Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024GlobeNewswire
- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $15.00 price target on the stock.MarketBeat
- Should You Sell Maravai LifeSciences (MRVI)? [Yahoo! Finance]Yahoo! Finance
MRVI
Earnings
- 2/22/24 - Beat
MRVI
Sec Filings
- 4/16/24 - Form 4
- 3/18/24 - Form 4
- 3/18/24 - Form 4
- MRVI's page on the SEC website